China Registration Study in Patients With Skin Infections
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The objectives of this study is to evaluate the Safety and Efficacy of Intravenous Daptomycin
(Cubicin®)Compared with that of Comparator (Vancomycin or Vancomycin Followed by
Semi-synthetic Penicillin-cloxacillin) in the Treatment of Chinese Subjects with Complicated
Bacterial Skin and Skin Structure Infection due to Gram-Positive Pathogens.